Abstract:CARTILAGE, Volume 13, Issue 3, July-September 2022. ObjectiveOsteoarthritis (OA) is characterized by the chronic and progressive deterioration of articular cartilage. Chondrocyte senescence could lead to a shift in the balance between extracellular matrix (ECM) component synthesis and degradation. Small noncoding RNAs (sncRNAs), including microRNAs (miRNAs), P-element-induced wimpy testis-(PIWI-) interacting RNAs (piRNAs), small nucleolar RNAs (snoRNAs), small nuclear RNAs (snRNAs), and repeat-associated siRNAs (rasiRNAs), are a class of important epigenetic molecules. We aimed to gain insights into the changes and roles of sncRNA in chondrocyte senescence.DesignHealthy mouse postnatal chondrocytes were isolated, and a replicative aging model was constructed. We used small RNA sequencing (small RNA-seq) to generate extensive small RNA data. We identified differentially expressed sncRNAs and performed tissue-specific analysis using real-time quantitative polymerase chain reaction (qRT-PCR). β-galactosidase staining was used to detect chondrocyte senescence. The results showed that the expression profiles of sncRNA in passage 5 chondrocytes were significantly different from those in passage 0 chondrocytes. The expression of sncRNA was tissue specific. We found that 40 miRNAs were upregulated and 70 miRNAs were downregulated during chondrocyte senescence, and that miR-132-5p expression inhibition prevented chondrocyte senescence. We found that 8 piRNAs were upregulated and 17 piRNAs were downregulated during chondrocyte senescence, and that piRNA piR_025576 overexpression delayed chondrocyte senescence. We found that 24 snoRNAs were upregulated and 28 snoRNAs were downregulated during chondrocyte senescence, and that snoRNA ENSMUSG00000087935 overexpression delayed chondrocyte senescence. We found that 5 snRNAs were upregulated and 6 snRNAs were downregulated during chondrocyte senescence, and that snRNA ENSMUSG00000064682 overexpression delayed chondrocyte senescence. We found that 1 rasiRNA was upregulated and 4 rasiRNAs were downregulated during chondrocyte senescence.ConclusionsThese findings might provide novel insights into OA pathogenesis and contribute to the development of candidates for targeted therapeutics in OA.

Senescence Features and Mechanisms of Chondrocytes

Regulation of senescence associated signaling mechanisms in chondrocytes for cartilage tissue regeneration

Wnt/β‑catenin Signaling May Induce Senescence of Chondrocytes in Osteoarthritis

Mechanisms and Regulation of Cellular Senescence

Events in Articular Chondrocytes with Aging

Cellular senescence in knee osteoarthritis: molecular mechanisms and therapeutic implications

Changes in Small Noncoding RNA Expression during Chondrocyte Senescence

Senescence in osteoarthritis: from mechanism to potential treatment

Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype

The role of mitochondrial quality control mechanisms in chondrocyte senescence

Transcriptomic Changes During the Replicative Senescence of Human Articular Chondrocytes

TDP-43 ameliorates aging-related cartilage degradation through preventing chondrocyte senescence

Cellular Senescence: Mechanisms and Therapeutic Potential

Senescent skeletal cells cross-talk with synovial cells plays a key role in the pathogenesis of osteoarthritis

Chondrocyte Aging: The Molecular Determinants and Therapeutic Opportunities

Small non-coding RNAome changes during human chondrocyte senescence as potential epigenetic targets in age-related osteoarthritis

Inflammatory and Metabolic Signaling Interfaces of the Hypertrophic and Senescent Chondrocyte Phenotypes Associated with Osteoarthritis

Autophagy and apoptosis: regulatory factors of chondrocyte phenotype transition in osteoarthritis

Interleukin-1β induced premature senescence of articular chondrocytes

Mechanisms of chondrocyte cell death in osteoarthritis: implications for disease progression and treatment

Epigenetic Regulation of Cellular Senescence